Cargando…
Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi
INTRODUCTION: Pneumonia is the leading infectious killer of children. We conducted a double-blind, randomised controlled non-inferiority trial comparing placebo to amoxicillin treatment for fast breathing pneumonia in HIV-negative children aged 2–59 months in Malawi. Occurrence of serious adverse ev...
Autores principales: | Nkwopara, Evangelyn, Schmicker, Robert, Mvalo, Tisungane, Phiri, Melda, Phiri, Ajib, Couasnon, Mari, McCollum, Eric D., Ginsburg, Amy Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733335/ https://www.ncbi.nlm.nih.gov/pubmed/31548894 http://dx.doi.org/10.1136/bmjresp-2019-000415 |
Ejemplares similares
-
Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis
por: Nkwopara, Evangelyn, et al.
Publicado: (2019) -
Repeat assessment of examination signs among children in Malawi with fast-breathing pneumonia
por: Lenahan, Jennifer L., et al.
Publicado: (2020) -
Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018) -
Malawian children with fast-breathing pneumonia with and without comorbidities
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021) -
Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
por: Ginsburg, Amy Sarah, et al.
Publicado: (2019)